Critical Contrast: Perrigo (NYSE:PRGO) & Merrimack Pharmaceuticals (NASDAQ:MACK)
Perrigo (NYSE:PRGO – Get Rating) and Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation. Insider and Institutional Ownership 89.0% of Perrigo shares are held by […]
Source: etfdailynews.com